- Nachrichtendetail
-
22.03.2024 13:01:57 - dpa-AFX: *ASTELLAS GETS POSITIVE CHMP OPINION FOR XTANDI IN ADDL RECURRENT EARLY PROSTATE CANCER TREATMENT SETTING
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTELLAS PHARMA INC. | 856273 | Frankfurt | 8,890 | 04.07.24 21:49:53 | +0,028 | +0,32% | 9,096 | 9,488 | 8,898 | 8,890 |
